BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27255693)

  • 1. MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review.
    Rocha H; Sampaio M; Rocha R; Fernandes S; Leão M
    Eur J Med Genet; 2016 Sep; 59(9):478-82. PubMed ID: 27255693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.
    Paciorkowski AR; Traylor RN; Rosenfeld JA; Hoover JM; Harris CJ; Winter S; Lacassie Y; Bialer M; Lamb AN; Schultz RA; Berry-Kravis E; Porter BE; Falk M; Venkat A; Vanzo RJ; Cohen JS; Fatemi A; Dobyns WB; Shaffer LG; Ballif BC; Marsh ED
    Neurogenetics; 2013 May; 14(2):99-111. PubMed ID: 23389741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive investigation of the phenotype of MEF2C-related disorders in human patients: A systematic review.
    Cooley Coleman JA; Sarasua SM; Boccuto L; Moore HW; Skinner SA; DeLuca JM
    Am J Med Genet A; 2021 Dec; 185(12):3884-3894. PubMed ID: 34184825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
    Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEF2C deletions and mutations versus duplications: a clinical comparison.
    Novara F; Rizzo A; Bedini G; Girgenti V; Esposito S; Pantaleoni C; Ciccone R; Sciacca FL; Achille V; Della Mina E; Gana S; Zuffardi O; Estienne M
    Eur J Med Genet; 2013 May; 56(5):260-5. PubMed ID: 23402836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements.
    Vrečar I; Innes J; Jones EA; Kingston H; Reardon W; Kerr B; Clayton-Smith J; Douzgou S
    J Pediatr Genet; 2017 Sep; 6(3):129-141. PubMed ID: 28794905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEF2C-related epilepsy: Delineating the phenotypic spectrum from a novel mutation and literature review.
    Borlot F; Whitney R; Cohn RD; Weiss SK
    Seizure; 2019 Apr; 67():86-90. PubMed ID: 30922778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
    Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
    J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroclinical features of MEF2C haploinsufficiency-related epilepsy: A multicenter European study.
    Raviglione F; Douzgou S; Scala M; Mingarelli A; D'Arrigo S; Freri E; Darra F; Giglio S; Bonaglia MC; Pantaleoni C; Mastrangelo M; Epifanio R; Elia M; Saletti V; Morlino S; Vari MS; De Liso P; Pavaine J; Spaccini L; Cattaneo E; Gardella E; Møller RS; Marchese F; Colonna C; Gandioli C; Gobbi G; Ram D; Palumbo O; Carella M; Germano M; Tonduti D; De Angelis D; Caputo D; Bergonzini P; Novara F; Zuffardi O; Verrotti A; Orsini A; Bonuccelli A; De Muto MC; Trivisano M; Vigevano F; Granata T; Bernardina BD; Tranchina A; Striano P
    Seizure; 2021 May; 88():60-72. PubMed ID: 33831796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial MEF2C deletion in a Cypriot patient with severe intellectual disability and a jugular fossa malformation: review of the literature.
    Tanteles GA; Alexandrou A; Evangelidou P; Gavatha M; Anastasiadou V; Sismani C
    Am J Med Genet A; 2015 Mar; 167A(3):664-9. PubMed ID: 25691421
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chen S; Deng X; Xiong J; Chen B; He F; Yang L; Yang L; Peng J; Yin F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):265-270. PubMed ID: 35545418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
    Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
    Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADGRV1 is implicated in myoclonic epilepsy.
    Myers KA; Nasioulas S; Boys A; McMahon JM; Slater H; Lockhart P; Sart DD; Scheffer IE
    Epilepsia; 2018 Feb; 59(2):381-388. PubMed ID: 29266188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel MEF2C point mutations in Chinese patients with Rett (-like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation.
    Wang J; Zhang Q; Chen Y; Yu S; Wu X; Bao X; Wen Y
    BMC Med Genet; 2018 Oct; 19(1):191. PubMed ID: 30376817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe neurodevelopmental disorder caused by an MEF2C nonsense mutation.
    Morisada N; Ishida Y; Tokumoto S; Maruyama A; Iijima K
    Pediatr Int; 2021 Dec; 63(12):1536-1538. PubMed ID: 34449120
    [No Abstract]   [Full Text] [Related]  

  • 16. Refining the phenotype associated with MEF2C point mutations.
    Bienvenu T; Diebold B; Chelly J; Isidor B
    Neurogenetics; 2013 Feb; 14(1):71-5. PubMed ID: 23001426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitt-Hopkins syndrome: report of a case with a TCF4 gene mutation.
    Taddeucci G; Bonuccelli A; Mantellassi I; Orsini A; Tarantino E
    Ital J Pediatr; 2010 Feb; 36():12. PubMed ID: 20205897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdeletion 5q14.3 and anomalies of brain development.
    Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
    Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New allelic variants of non-syndromic mental retardation of type 20 caused by mutations in the MEF2C gene].
    Anisimova IV; Dadali EL; Konovalov FA; Akimova IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):70-75. PubMed ID: 29863696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.